Shingles vaccine can slash risk of dementia, study suggests

A shingles vaccine could cut the risk of dementia (Nick Potts/PA) - (PA Wire)

Researchers tracking dementia cases in UK adults have discovered the shingles vaccine could cut the risk of patients developing the disease.

Health data of more than 280,000 adults revealed adults who received a discontinued shingles vaccine called Zostavax were 20 per cent less likely to develop dementia over a period of seven years than those who did not.